T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses
Open Access
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 23 (5) , 964-973
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Oncolytic Immunotherapy: Where Are We Clinically?Scientifica, 2014
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer PatientsMolecular Therapy, 2013
- An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor ClearanceMolecular Therapy, 2012
- Oncolytic Viruses for Induction of Anti-Tumor ImmunityCurrent Pharmaceutical Biotechnology, 2012
- Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced CancerMolecular Therapy, 2012
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor ControlCancer Research, 2011
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic CorrelatesJournal of Clinical Oncology, 2010
- Immune infiltration in human tumors: a prognostic factor that should not be ignoredOncogene, 2009
- Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancerCancer, 2008
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008